MIDAS Strategy: Minimizing Implantat Depth According to Membranous Septum

Permanent pacemaker implantation following transcatheter aortic valve replacement (TAVR) continues to be one of the most frequent complications. Even though its real impact on prognosis continues to be controversial, its impact on healthcare cost is out of the question, in addition to being uncomfortable for patients. 

¿Fin de la discusión sobre el impacto del marcapaso post TAVI?

This study, soon to be published in J Am Coll Cardiol Intv, sought a way to minimize the risk of pacemaker implantation post TAVR with contemporary repositionable self-expanding transcatheter aortic valve replacement (TAVR).

It included 248 consecutive severe aortic stenosis patients undergoing self-expanding TAVR under conscious sedation with standard approach. Researchers looked at multiple factors that might contribute to definite pacemaker implantation rate and created an anatomically guided minimizing depth according to membranous septum (MIDAS). The idea behind this technique is to minimize implant depth relative to non-coronary sinus/ membranous septum distance. 


Read also: The Era of Provisional Stenting for Bifurcations Comes to an End.


Pacemaker implantation predictors post TAVR were prior right bundle branch block, membranous septum length, larger devices (Evolut 34 XL) and deeper implantation relative to non-coronary cusp /membranous septum distance.

At multivariable analyzis, the only independent predictors were deeper implantation than the distance to membranous sinus (OR: 8.04 CI 95%: 2.58 to 25.04]; p<0.001) and Evolut 34 XL prosthesis (OR: 4.96 CI 95%: 1.68 to 14.63]; p=0.004).

The MIDAS technique was done prospectively in 100 consecutive patients after this analyzis. Operators’ goal was pre-release depth in relation to the noncoronary cusp of less than the length of the membranous septum.

With this technique, researchers succeeded in reducing pacemaker implantation rate from 9.7% to 3% (p=0.035) and left bundle branch block from 25.8% to 9% (p<0.001).

Conclusion

Using the MIDAS technique, we can find the right implantation depth specific to each patient, which predicts and reduces definite pacemaker implantation rate post self-expandable contemporary valve implantation. 

Original Title: Minimizing Permanent Pacemaker Following Repositionable Self-Expanding Transcatheter Aortic Valve Replacement.

Reference: Hasan Jilaihawi et al. J Am Coll Cardiol Intv 2019, online before print.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

TCT 2025 | ANDES Trial: Short-Term DOAC vs. DAPT After Percutaneous Left Atrial Appendage Occlusion

Percutaneous left atrial appendage occlusion (LAAO) is an established alternative to chronic anticoagulation in patients with non-valvular atrial fibrillation (AFib). A clinically relevant complication...

TCT 2025 | SUMMIT-MAC: Transcatheter Mitral Valve Replacement with the Tendyne System in Patients with Severe Annular Calcification

The prospective, multicenter SUMMIT-MAC study evaluated the safety and efficacy of transcatheter mitral valve replacement (TMVR) using the Tendyne system in patients with severe...

TCT 2025 | PREVUE-VALVE: Prevalence of Valvular Heart Disease in Elderly US Patients

The PREVUE-VALVE study was designed to determine the true prevalence and demographic determinants of valvular heart disease in US elderly population using a decentralized,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

CALIPSO: Calcified Lesions and Use of OCT

Percutaneous coronary intervention (PCI) in calcified lesions remains one of the most challenging scenarios in daily practice, as these lesions are often accompanied by...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...